Pramipexole is a dopamine agonist with higher affinity for D3 receptors. Treatment with pramipexole in clinical conditions such as restless legs syndrome, fibromyalgia, and parkinsonism has been found to significantly improve measures of pain and sleep along with the other symptoms. There is no research data available that explores the usefulness of pramipexole in somatoform/functional pain syndromes. We report a case of a 65-year-old male with bilateral functional shoulder pain associated with insomnia and zolpidem dependence effectively treated with pramipexole
A 45 year old male sought consultation in our neurology clinic with the complaint of persistent geni...
Zolpidem is usually used for the treatment of insomnia as a hypnotic drug. It was also suggested to ...
Francesca Brindani, Francesca Vitetta, Franco GemignaniDepartment of Neurosciences, University of Pa...
WOS: 000442221000009PubMed ID: 29493461Background: The causal link between upper limb restlessness a...
Recent case reports suggest a possible causal correlation between antecollis and pramipexole. Here, ...
Background: There is still speculative data regarding the role of spinal dopaminergic neurotransmiss...
Pramipexole is a non-ergoline dopamine agonist with a high selectivity for D2 and D2 receptors. Init...
Objective. To assess the efficacy and safety of pramipexole, a dopamine 3 receptor agonist, in patie...
BACKGROUND: Pramipexole is a D3 dopaminergic agonist that has shown a major effect on both sensory ...
Dopamine agonists, particularly nonergot dopamine agonists such as pramipexole, have become the main...
Dopamine agonists, particularly nonergot dopamine agonists such as pramipexole, have become the main...
WOS: 000297959300008Efficacy of low-dose pramipexole augmentation in the treatment of refractory psy...
BACKGROUND: Dopamine agonists (DAs) represent the first-line treatment in restless legs syndrome (RL...
Efficacy of low-dose pramipexole augmentation in the treatment of refractory psychotic depression co...
Wei Zhang, Ye Wang, Shu Yan Cong, Jian Fei Nao, Juan Feng, Guo Rong Bi Neurology Department, Shengji...
A 45 year old male sought consultation in our neurology clinic with the complaint of persistent geni...
Zolpidem is usually used for the treatment of insomnia as a hypnotic drug. It was also suggested to ...
Francesca Brindani, Francesca Vitetta, Franco GemignaniDepartment of Neurosciences, University of Pa...
WOS: 000442221000009PubMed ID: 29493461Background: The causal link between upper limb restlessness a...
Recent case reports suggest a possible causal correlation between antecollis and pramipexole. Here, ...
Background: There is still speculative data regarding the role of spinal dopaminergic neurotransmiss...
Pramipexole is a non-ergoline dopamine agonist with a high selectivity for D2 and D2 receptors. Init...
Objective. To assess the efficacy and safety of pramipexole, a dopamine 3 receptor agonist, in patie...
BACKGROUND: Pramipexole is a D3 dopaminergic agonist that has shown a major effect on both sensory ...
Dopamine agonists, particularly nonergot dopamine agonists such as pramipexole, have become the main...
Dopamine agonists, particularly nonergot dopamine agonists such as pramipexole, have become the main...
WOS: 000297959300008Efficacy of low-dose pramipexole augmentation in the treatment of refractory psy...
BACKGROUND: Dopamine agonists (DAs) represent the first-line treatment in restless legs syndrome (RL...
Efficacy of low-dose pramipexole augmentation in the treatment of refractory psychotic depression co...
Wei Zhang, Ye Wang, Shu Yan Cong, Jian Fei Nao, Juan Feng, Guo Rong Bi Neurology Department, Shengji...
A 45 year old male sought consultation in our neurology clinic with the complaint of persistent geni...
Zolpidem is usually used for the treatment of insomnia as a hypnotic drug. It was also suggested to ...
Francesca Brindani, Francesca Vitetta, Franco GemignaniDepartment of Neurosciences, University of Pa...